Jingwen Li1, Xi Long2, Heqing Huang3, Jine Tang4, Chunli Zhu5, Shaoping Hu6, Jing Wu7, Jinghong Li8, Zhicheng Lin9, Nian Xiong1,5. 1. Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. 2. Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. 3. Department of Pediatrics, People's Hospital of Dongxihu District, Wuhan, Hubei, China. 4. Department of Science and Education, Wuhan Red Cross Hospital, Wuhan, Hubei, China. 5. Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei, China. 6. Department of Radiology, Wuhan Red Cross Hospital, Wuhan, Hubei, China. 7. Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. 8. Department of Medicine, University of California San Diego, La Jolla, CA, USA. 9. Laboratory of Psychiatric Neurogenomics, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Abstract
BACKGROUND: Facing the novel coronavirus disease 2019 (COVID-19), most vulnerable individuals are seniors, especially those with comorbidities. More attention needs to been paid to the COVID-19 patients with Alzheimer's disease (AD), which is the top age-related neurodegenerative disease. OBJECTIVE: Since it is unclear whether AD patients are prone to COVID-19 infection and progression to severe stages, we report for the first time a retrospective analysis of the clinical characteristics of AD patients with COVID-19 pneumonia. METHODS: We conducted a retrospective cohort study of the clinical data of 19 AD patients with COVID-19 pneumonia, compared with 23 non-AD COVID-19 patients admitted at the same time to our hospital. Demographic, clinical, laboratory, radiological, and treatment data were collected and analyzed. RESULTS: Between AD patients and non-AD patients with COVID-19 pneumonia, the pneumonia severity was not significantly different. AD patients had a higher clustering onset than non-AD patients. The median duration from symptom onset to hospitalization were shorter in AD patients than non-AD patients, indicating the former were sent to the hospital by their family or from nursing home earlier than the later. The median duration from hospitalization to discharge seemed shorter in AD patients than non-AD patients. Dementia patients seemed less likely to report fatigue. It is noticed that more AD patients might have pericardial effusion than the non-AD patients. CONCLUSION: AD patients with COVID-19 were in milder conditions with a better prognosis than non-AD patients. AD patients who had adequate access to healthcare showed resilience to COVID-19 with shorter hospital stays.
BACKGROUND: Facing the novel coronavirus disease 2019 (COVID-19), most vulnerable individuals are seniors, especially those with comorbidities. More attention needs to been paid to the COVID-19patients with Alzheimer's disease (AD), which is the top age-related neurodegenerative disease. OBJECTIVE: Since it is unclear whether ADpatients are prone to COVID-19infection and progression to severe stages, we report for the first time a retrospective analysis of the clinical characteristics of ADpatients with COVID-19 pneumonia. METHODS: We conducted a retrospective cohort study of the clinical data of 19 ADpatients with COVID-19 pneumonia, compared with 23 non-ADCOVID-19patients admitted at the same time to our hospital. Demographic, clinical, laboratory, radiological, and treatment data were collected and analyzed. RESULTS: Between ADpatients and non-ADpatients with COVID-19 pneumonia, the pneumonia severity was not significantly different. ADpatients had a higher clustering onset than non-ADpatients. The median duration from symptom onset to hospitalization were shorter in ADpatients than non-ADpatients, indicating the former were sent to the hospital by their family or from nursing home earlier than the later. The median duration from hospitalization to discharge seemed shorter in ADpatients than non-ADpatients. Dementiapatients seemed less likely to report fatigue. It is noticed that more ADpatients might have pericardial effusion than the non-ADpatients. CONCLUSION:ADpatients with COVID-19 were in milder conditions with a better prognosis than non-ADpatients. ADpatients who had adequate access to healthcare showed resilience to COVID-19 with shorter hospital stays.
Authors: Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: Aamira J Huq; Peter Fransquet; Simon M Laws; Joanne Ryan; Robert Sebra; Colin L Masters; Ingrid M Winship; Paul A James; Paul Lacaze Journal: Alzheimers Dement Date: 2019-09-07 Impact factor: 21.566
Authors: Charles E Evans; James S Miners; Giulia Piva; Christine L Willis; David M Heard; Emma J Kidd; Mark A Good; Patrick G Kehoe Journal: Acta Neuropathol Date: 2020-01-25 Impact factor: 15.887
Authors: Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann Journal: Cell Date: 2020-03-05 Impact factor: 41.582
Authors: Qiang Zhang; Jordan L Schultz; Georgina M Aldridge; Jacob E Simmering; Youngcho Kim; Amy C Ogilvie; Nandakumar S Narayanan Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160
Authors: Kathy Y Liu; Robert Howard; Sube Banerjee; Adelina Comas-Herrera; Joanne Goddard; Martin Knapp; Gill Livingston; Jill Manthorpe; John T O'Brien; Ross W Paterson; Louise Robinson; Martin Rossor; James B Rowe; David J Sharp; Andrew Sommerlad; Aida Suárez-González; Alistair Burns Journal: Int J Geriatr Psychiatry Date: 2021-05-27 Impact factor: 3.850